Literature DB >> 23681959

CROI 2013: Basic science review.

Mario Stevenson1.   

Abstract

The 20th Conference on Retroviruses and Opportunistic Infections was held in Atlanta, Georgia, and featured strong coverage in several basic science categories. Presentations on viral reservoir and cure research covered a variety of topics, including approaches to gauge viral reservoir size in patients on suppressive antiretroviral therapy, approaches to reactivate latently infected cells, and the role of residual replication in viral persistence under antiretroviral therapy. Research on viral restriction factors remains a strong feature of the conference, and presentations on the impact of viral restrictions on the establishment of viral reservoirs, as well as strategies that harness the antiviral potential of cellular restrictions, generated a lot of interest. Several studies on the nature of proviral latency left us with the sobering message that elimination of the latent viral pool is going to be an even greater challenge than previously suspected.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23681959      PMCID: PMC6148868     

Source DB:  PubMed          Journal:  Top Antivir Med        ISSN: 2161-5853


  5 in total

1.  HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects.

Authors:  Maria J Buzón; Marta Massanella; Josep M Llibre; Anna Esteve; Viktor Dahl; Maria C Puertas; Josep M Gatell; Pere Domingo; Roger Paredes; Mark Sharkey; Sarah Palmer; Mario Stevenson; Bonaventura Clotet; Julià Blanco; Javier Martinez-Picado
Journal:  Nat Med       Date:  2010-03-14       Impact factor: 53.440

2.  T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virus-infected patients with sustained viral suppression during antiretroviral therapy.

Authors:  Peter W Hunt; Jeffrey N Martin; Elizabeth Sinclair; Barry Bredt; Elilta Hagos; Harry Lampiris; Steven G Deeks
Journal:  J Infect Dis       Date:  2003-04-23       Impact factor: 5.226

3.  Siglec-1 is a novel dendritic cell receptor that mediates HIV-1 trans-infection through recognition of viral membrane gangliosides.

Authors:  Nuria Izquierdo-Useros; Maier Lorizate; Maria C Puertas; Maria T Rodriguez-Plata; Nadine Zangger; Elina Erikson; Maria Pino; Itziar Erkizia; Bärbel Glass; Bonaventura Clotet; Oliver T Keppler; Amalio Telenti; Hans-Georg Kräusslich; Javier Martinez-Picado
Journal:  PLoS Biol       Date:  2012-12-18       Impact factor: 8.029

4.  Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

Authors:  Lewis H Kuller; Russell Tracy; Waldo Belloso; Stephane De Wit; Fraser Drummond; H Clifford Lane; Bruno Ledergerber; Jens Lundgren; Jacqueline Neuhaus; Daniel Nixon; Nicholas I Paton; James D Neaton
Journal:  PLoS Med       Date:  2008-10-21       Impact factor: 11.069

5.  Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy.

Authors:  N M Archin; A L Liberty; A D Kashuba; S K Choudhary; J D Kuruc; A M Crooks; D C Parker; E M Anderson; M F Kearney; M C Strain; D D Richman; M G Hudgens; R J Bosch; J M Coffin; J J Eron; D J Hazuda; D M Margolis
Journal:  Nature       Date:  2012-07-25       Impact factor: 49.962

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.